GoAI
Get started
GNI Group Ltd. logo

GNI Group Ltd.

2160.T

JPXHealthcareBiotechnology

Open in GoAI

Latest quote

¥2,701

−¥85.00 · -3.05%

Aug 24, 3:30 PM JST

2160.T company overview

Regular session · JST · Market data may be delayed.

Company profile

Company website

GNI Group Ltd. is a global biopharmaceutical enterprise dedicated to the research, development, manufacturing, and commercialization of both modern pharmaceuticals and traditional Chinese medicines. The company's lead product, Etuary, is currently available for the treatment of idiopathic pulmonary fibrosis. Beyond this, Etuary is undergoing further clinical evaluation: it is in Phase III trials for connective tissue disease-associated interstitial lung disease, and in Phase II along with a pre-Phase III pilot study for radiation pneumonitis. Investigations are also underway for its application in diabetic nephropathy. GNI Group Ltd.'s pipeline additionally features F351, which is in Phase II development for liver fibrosis; F573, an early-stage compound in pre-clinical testing for acute-on-chronic liver failure; and Tamibarotene, intended for the treatment of acute promyelocytic leukemia. Established in 2001, the company's headquarters are located in Tokyo, Japan.

Industry
Biotechnology
Sector
Healthcare
Headquarters
JP
CEO
Ying Luo
Listed since
Aug 31, 2007
Employees
990

Market position

Day range

Current ¥2,701

52-week range

Current ¥2,701

Open
¥2,766
Previous close
¥2,786
Volume
1.52M
1.4× average
Average volume
1.08M
Average daily volume
Market cap
177.74B JPY
Beta
1.22
Market reference 1
50-day average
¥2,641.46
+2.25% above average
200-day average
¥2,740.18
-1.43% below average

Financials

Financial snapshot

Latest / TTM

Financial health

Altman Z-score
7.9
Piotroski F-score
3 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends98%56%15%-27%Gross margin, FY2021: 87.39%Gross margin, FY2022: 84.65%Gross margin, FY2023: 86.24%Gross margin, FY2024: 76.39%Gross margin, FY2025: 74.49%Operating margin, FY2021: 8.79%Operating margin, FY2022: 7.08%Operating margin, FY2023: 17.61%Operating margin, FY2024: -2.31%Operating margin, FY2025: -8.60%Net margin, FY2021: 8.40%Net margin, FY2022: 2.23%Net margin, FY2023: 31.12%Net margin, FY2024: 4.65%Net margin, FY2025: -16.44%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 87.39%. Gross margin FY2022 84.65%. Gross margin FY2023 86.24%. Gross margin FY2024 76.39%. Gross margin FY2025 74.49%. Operating margin FY2021 8.79%. Operating margin FY2022 7.08%. Operating margin FY2023 17.61%. Operating margin FY2024 -2.31%. Operating margin FY2025 -8.60%. Net margin FY2021 8.40%. Net margin FY2022 2.23%. Net margin FY2023 31.12%. Net margin FY2024 4.65%. Net margin FY2025 -16.44%.

Income trends

Revenue

26.84B JPY+13.67%

Operating income

−2.31B JPY-322.10%

Net income

−4.41B JPY−5.51B JPY
Income trends across reported periods29.97B JPY17.46B JPY4.96B JPY−7.54B JPYRevenue, FY2021: 12.69B JPYRevenue, FY2022: 17.42B JPYRevenue, FY2023: 26.01B JPYRevenue, FY2024: 23.61B JPYRevenue, FY2025: 26.84B JPYOperating income, FY2021: 1.12B JPYOperating income, FY2022: 1.23B JPYOperating income, FY2023: 4.58B JPYOperating income, FY2024: −546.55M JPYOperating income, FY2025: −2.31B JPYNet income, FY2021: 1.07B JPYNet income, FY2022: 388.83M JPYNet income, FY2023: 8.09B JPYNet income, FY2024: 1.1B JPYNet income, FY2025: −4.41B JPYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 12.69B JPY. Revenue FY2022 17.42B JPY. Revenue FY2023 26.01B JPY. Revenue FY2024 23.61B JPY. Revenue FY2025 26.84B JPY. Operating income FY2021 1.12B JPY. Operating income FY2022 1.23B JPY. Operating income FY2023 4.58B JPY. Operating income FY2024 −546.55M JPY. Operating income FY2025 −2.31B JPY. Net income FY2021 1.07B JPY. Net income FY2022 388.83M JPY. Net income FY2023 8.09B JPY. Net income FY2024 1.1B JPY. Net income FY2025 −4.41B JPY.
Metric (JPY)FY2025FY2024FY2023FY2022FY2021
Revenue26.84B JPY23.61B JPY26.01B JPY17.42B JPY12.69B JPY
Cost of goods sold6.85B JPY5.57B JPY3.58B JPY2.67B JPY1.6B JPY
Gross profit19.99B JPY18.04B JPY22.43B JPY14.74B JPY11.09B JPY
Research and development3.3B JPY2.81B JPY2.56B JPY2.55B JPY2.02B JPY
Selling, general, and administrative19B JPY15.77B JPY15.29B JPY10.97B JPY7.96B JPY
Operating expenses22.3B JPY18.58B JPY17.85B JPY13.51B JPY9.97B JPY
Interest income578M JPY648.22M JPY332.05M JPY122.25M JPY69.25M JPY
Interest expense1.75B JPY1.45B JPY1.25B JPY869.89M JPY647.9M JPY
Depreciation and amortization1.14B JPY983.24M JPY608.42M JPY521.67M JPY383.03M JPY
Operating income−2.31B JPY−546.55M JPY4.58B JPY1.23B JPY1.12B JPY
Net income−4.41B JPY1.1B JPY8.09B JPY388.83M JPY1.07B JPY

Company facts updated Aug 24, 2026.

ETFs holding 2160.T

Funds reporting this stock among their holdings, ordered by reported position size.

iShares Core MSCI EAFE ETF logoiShares Core MSCI EAFE ETFIEFA
Market value
7.54M
Weight
0.00%
AUM
195.14B USD
Expense ratio
0.07%
Price / 1D
$100.85+0.86%
iShares MSCI EAFE Small-Cap ETF logoiShares MSCI EAFE Small-Cap ETFSCZ
Market value
3.59M
Weight
0.03%
AUM
13.28B USD
Expense ratio
0.40%
Price / 1D
$86.60+0.70%
iShares Core MSCI Total International Stock ETF logoiShares Core MSCI Total International Stock ETFIXUS
Market value
1.85M
Weight
0.00%
AUM
60.91B USD
Expense ratio
0.07%
Price / 1D
$97.945+0.76%
State Street SPDR Portfolio Developed World ex-US ETF logoState Street SPDR Portfolio Developed World ex-US ETFSPDW
Market value
1.58M
Weight
0.00%
AUM
41.92B USD
Expense ratio
0.03%
Price / 1D
$52.02+0.79%
iShares Core MSCI International Developed Markets ETF logoiShares Core MSCI International Developed Markets ETFIDEV
Market value
1.29M
Weight
0.00%
AUM
32.6B USD
Expense ratio
0.04%
Price / 1D
$93.31+0.82%
State Street SPDR S&P International Small Cap ETF logoState Street SPDR S&P International Small Cap ETFGWX
Market value
362.36K
Weight
0.04%
AUM
927.26M USD
Expense ratio
0.40%
Price / 1D
$46.205+0.40%
iShares Core MSCI Pacific ETF logoiShares Core MSCI Pacific ETFIPAC
Market value
345.59K
Weight
0.01%
AUM
2.76B USD
Expense ratio
0.09%
Price / 1D
$85.16+0.91%
iShares MSCI Japan Small-Cap ETF logoiShares MSCI Japan Small-Cap ETFSCJ
Market value
180.17K
Weight
0.07%
AUM
259.46M USD
Expense ratio
0.50%
Price / 1D
$108.36+0.64%

Continue in GoAI

Research 2160.T

research.disclaimer